微信公众号

官网二维码
中国癌症防治杂志

中国癌症防治杂志

• 论文 • 上一篇    下一篇

三维适形放射治疗肝癌55例疗效分析

陈娜;林锦;刘秀英;吴君心;   

  1. 福建省肿瘤医院放疗科;
  • 收稿日期:2009-06-25 修回日期:2009-06-25 出版日期:2009-06-25 发布日期:2009-06-25

Analyses of 55 cases of liver cancer treated with 3-dimentional conformal radiotherapy

CHEN Na,LIN Jing,LIU Xiu-ying,et al.   

  1. (Department of Radiation Oncology,Fujian Provincial Tumor Hospital,Fuzhou Fujian 350014,China
  • Received:2009-06-25 Revised:2009-06-25 Online:2009-06-25 Published:2009-06-25

赞

摘要： 目的观察评价三维适形放射治疗技术(3-DCRT)治疗原发及继发性肝癌的治疗疗效。方法1998年11月至2007年12月对55例原发及继发性肝癌患者进行3-DCRT治疗,总剂量D_T45～60Gy/15～30F,3～6w,正常肝组织V_(30)<33%。结果55例患者中,CR 6例(10.9%),PR 26例(47.3%),NC 15例(27.3%),PD 8例(14.5%),总有效率(CR+PR)58.2%。1、2、3年生存率分别为67.3%(37/55)、34.9%(15/43)、23.3%(7/30)。结论3-DCRT治疗肝癌安全有效,毒副反应小。

关键词: 肝肿瘤, 放射疗法, 适形, 治疗效果

Abstract: Objective To evaluate the treatment effect of 3-dimentional conformal radiotherapy(3-DCRT) on the patients with primary or secondary liver cancer.Method 55 patients with primary or secondary liver cancer from November 1998 to December 2007 were treated with 3-DCRT.The total doses were DT45-60Gy/15-30F/3-6w,and the V_(30) of normal liver tissue was<33%. Results of 55 patients,there were 6(10.9%) patients with CR,26(47.3%) with PR,15(27.3%) with NC and 8(14.5%) with PD.The total effective rate(CR + PR) was 58.2%.The one-,two- and three-year survival rates were 67.3%(37/55), 34.9%(15/43) and 23.3%(7/30),respectively.Conclusions 3-DCRT is effective and safe for the patients with liver cancer, and its side effect is slight.

Key words: Liver neoplasm, Radiotherapy, Conformal radiation